Adverse event totals12

The totals the trial posted for each group.

1 to 12 of 12

Total	Group	Affected	At risk
Total, all-cause mortality	LY 2127399 Q2W Treatment
Total, all-cause mortality	LY2127399 Q4W Treatment
Total, all-cause mortality	LY 2127399 Q2W Follow Up
Total, all-cause mortality	LY2127399 Q4W Follow Up
Total, other adverse events	LY 2127399 Q2W Treatment	464	937
Total, other adverse events	LY2127399 Q4W Treatment	232	578
Total, other adverse events	LY 2127399 Q2W Follow Up	37	810
Total, other adverse events	LY2127399 Q4W Follow Up	24	526
Total, serious adverse events	LY 2127399 Q2W Treatment	129	937
Total, serious adverse events	LY2127399 Q4W Treatment	64	578
Total, serious adverse events	LY 2127399 Q2W Follow Up	57	810
Total, serious adverse events	LY2127399 Q4W Follow Up	51	526

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01488708/event-totals